Startup Member Companies

GREGOR DIAGNOSTICS: Better screening for prostate cancer   A molecular diagnostics company developing a revolutionary screening test for prostate cancer, the second deadliest cancer for men. Gregor Diagnostic’s technology can accurately determine if an asymptomatic patient has no cancer, indolent cancer, or aggressive cancer.

GREGOR DIAGNOSTICS: Better screening for prostate cancer

A molecular diagnostics company developing a revolutionary screening test for prostate cancer, the second deadliest cancer for men. Gregor Diagnostic’s technology can accurately determine if an asymptomatic patient has no cancer, indolent cancer, or aggressive cancer.

EMPIRICO: A next generation therapeutics company   A therapeutics company founded on using medical data sets, human genetics and programmable biology to power novel target discovery and development. Empirico’s  Precision Insights Platform  was purpose-built for target discovery.  With it’s proprietary algorithms, the platform enables Empirico’s scientists to systematically generate, interrogate, and prioritize high-confidence therapeutic hypotheses.

EMPIRICO: A next generation therapeutics company

A therapeutics company founded on using medical data sets, human genetics and programmable biology to power novel target discovery and development. Empirico’s Precision Insights Platform was purpose-built for target discovery. With it’s proprietary algorithms, the platform enables Empirico’s scientists to systematically generate, interrogate, and prioritize high-confidence therapeutic hypotheses.

VASCUGEN: Advancing regenerative medicines for vascular diseases   A regenerative medicine company engaged in the development of advanced therapies to treat incurable conditions caused by loss or degeneration of blood vessels. The company has exclusive, worldwide rights to a broad patent portfolio for its platform technology that enables the functional restoration of blood vessels in any organ or tissue for research, diagnostics, therapeutics, tissue engineering, organoid and 3D bio-printing applications.

VASCUGEN: Advancing regenerative medicines for vascular diseases

A regenerative medicine company engaged in the development of advanced therapies to treat incurable conditions caused by loss or degeneration of blood vessels. The company has exclusive, worldwide rights to a broad patent portfolio for its platform technology that enables the functional restoration of blood vessels in any organ or tissue for research, diagnostics, therapeutics, tissue engineering, organoid and 3D bio-printing applications.

 
DIANOMI THERAPEUTICS: Developing next gen therapeutics for inflammatory diseases   A biopharmaceutical company advancing a pipeline of next generation treatments for inflammatory diseases, targeting osteoarthritis and pain. Their proprietary Mineral Coated Microparticle (MCM) technology is designed to provide proven drugs with sustained release delivery for improved stability, safety and efficacy.

DIANOMI THERAPEUTICS: Developing next gen therapeutics for inflammatory diseases

A biopharmaceutical company advancing a pipeline of next generation treatments for inflammatory diseases, targeting osteoarthritis and pain. Their proprietary Mineral Coated Microparticle (MCM) technology is designed to provide proven drugs with sustained release delivery for improved stability, safety and efficacy.

POLYMER FORGE: Accelerating progress in healthcare, biological research, and nanotechnology   Polymer Forge leverages and integrates the latest advantages in optoelectrics and combinatorial chemistry to develop novel products and applications for the emerging market in complex organic heteropolymers.

POLYMER FORGE: Accelerating progress in healthcare, biological research, and nanotechnology

Polymer Forge leverages and integrates the latest advantages in optoelectrics and combinatorial chemistry to develop novel products and applications for the emerging market in complex organic heteropolymers.

NANOSUR: Next generation smart pesticides   NanoSUR’s innovative platform enables broad use of RNAi in agriculture, and has developed modified RNA-based products for crop protection. Their proprietary platform produces modified RNA formulations with improved transport properties, resulting in enhanced target delivery and increased efficacy for RNAi.

NANOSUR: Next generation smart pesticides

NanoSUR’s innovative platform enables broad use of RNAi in agriculture, and has developed modified RNA-based products for crop protection. Their proprietary platform produces modified RNA formulations with improved transport properties, resulting in enhanced target delivery and increased efficacy for RNAi.